News | Breast Imaging | April 06, 2018

ACR/SBI Breast Cancer Screening Guidelines Reclassify African-American Women as High-Risk

Guidelines assign special status and approach for African-American and other women at high risk for breast cancer

ACR/SBI Breast Cancer Screening Guidelines Reclassify African-American Women as High-Risk

April 6, 2018 — New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening guidelines are the first to recognize that African-American women are at high-risk for the disease and should be screened as such. The ACR and SBI now call for all women to have a risk assessment at age 30 to see if screening earlier than age 40 is needed. The societies also newly-recommend that women previously diagnosed with breast cancer be screened with magnetic resonance imaging (MRI).

The ACR and SBI continue to recommend that women at average breast cancer risk begin screening at age 40.

“The latest scientific evidence overwhelmingly supports a continued general recommendation of starting annual screening at age 40. It also supports augmented and earlier screening for many women. These updates will help save more lives,” said Debra Monticciolo, M.D., FACR, chair of the American College of Radiology Breast Imaging Commission.

According to 2015 National Cancer Institute Surveillance, Epidemiology and End Results (SEER) data, since mammography became widespread in the 1980s, the U.S. breast cancer death rate in women has dropped 43 percent; it had been unchanged for the previous 50 years. Breast cancer deaths in men, who have the same treatment as women but are not screened, have not declined.

Factors that contributed to the ACR/SBI reclassification of African-American women include that:

  • African-American women are 42 percent more likely to die from breast cancer than non-Hispanic white women despite roughly equal incidence rates;
  • African-American women have a two-fold higher risk of aggressive — “triple-negative” — breast tumors;
  • African-American women are less likely to be diagnosed with stage I breast cancer, but twice as likely to die of early breast cancers; and
  • African-American women have a higher risk of BRCA1 and BRCA2 genetic mutations than those of Western European ancestry. These carriers are at much higher risk for breast cancer.

“Since 1990, breast cancer death rates dropped 23 percent in African-American women — approximately half that in whites. We changed our approach to help save more African-American women and others at higher risk from this deadly disease,” said Wendy B. DeMartini, M.D., FSBI.

For more information: www.endtheconfusion.org

Related Breast Imaging Content

ACR Recommends More Aggressive Breast Cancer Screening for Higher-Than-Average-Risk Women

 

Related Content

Mammography, which is an X-ray picture of the breast, is efficient also for women over the age of 70.

Getty Images

News | Mammography | October 22, 2020
October 22, 2020 — ...
Rebrand reflects Volpara Health's mission to prevent advanced-stage breast cancer
News | Breast Imaging | October 19, 2020
October 19, 2020 — Volpara Solutions, a leader in AI-powered breast density assessment, announced that it has changed
More than 600,000 women die of advanced breast cancer annually. (1) There is a safe, universally obtainable method to reduce this terrible toll according to MammaCare Foundation scientist Mark Kane Goldstein, Ph.D.

Module 1

News | Women's Health | October 15, 2020
October 15, 2020 — More than 600,000 women die of advanced breast cancer annually. ...
Released in the lead up to #DenseBreastDay (30 September) and Breast Cancer Awareness Month (October), the animation explains how breast density can complicate mammogram screening and make it harder for medical professionals to detect breast cancer. This highly engaging animation shows a polar bear hiding in a snow globe as an analogy for cancer hiding in dense breast tissue. 

Image provided by Dilon

News | Breast Density | October 07, 2020
October 7, 2020 — A group of Australia’s leading breast can...
Microscopic photo of a professionally prepared slide demonstrating breast tissue with ductal carcinoma in situ (DCIS). Immuhistochemistry of estrogen receptor positive. Micrograph of breast cancer. Slide shows corresponding length of 1 mm.

Microscopic photo of a professionally prepared slide demonstrating breast tissue with ductal carcinoma in situ (DCIS). Immuhistochemistry of estrogen receptor positive. Micrograph of breast cancer. Slide shows corresponding length of 1 mm. Getty Images

News | Breast Imaging | October 05, 2020
October 5, 2020 — A major study of women with ductal carcinoma in situ (...
ASTRO urges radiation oncology benefits management company eviCore to reconsider a move that requires shorter treatment regimens without regard for physician judgement

Getty Images

News | Radiation Oncology | October 02, 2020
October 2, 2020 — Radiation oncologists expressed serious concerns about a new private insurance coverage policy that